TRANSMEDICS GROUP INC (TMDX)

US89377M1099 - Common Stock

92.08  +2.83 (+3.17%)

After market: 92.8 +0.72 (+0.78%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
30.26M
18.02%		93.46M
208.86%		241.623M
158.53%		374.33M
54.92%
EBITDA
YoY % growth
-37.61M
-51.65%		-27.96M
25.66%		-18.55M
33.66%		16.602M
189.50%
EBIT
YoY % growth
-39.43M
-49.47%		-31.44M
20.26%		-26.727M
14.99%		1.704M
106.38%
Operating Margin
-130.30%-33.64%-11.06%0.46%
EPS
YoY % growth
-1.61
-34.17%		-1.25
22.36%		-0.77
38.40%		-0.23
70.06%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.05
33.70%
Revenue
Q2Q % growth		85.453M
105.66%
EBITDA
Q2Q % growth		11.322MN/AN/AN/AN/A
EBIT
Q2Q % growth		638.52K
130.55%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.12
157.14%		-0.030.15492.16%
Q3 2023
Q2Q % growth		 -0.78
-212.00%		-0.16-0.62-373.00%
Q2 2023
Q2Q % growth		 -0.03
92.68%		-0.130.1077.38%
Q1 2023
Q2Q % growth		 -0.08
78.95%		-0.250.1768.12%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 81.174M
158.68%		69.877M11.297M16.17%
Q3 2023
Q2Q % growth		 66.43M
158.68%		50.172M16.258M32.40%
Q2 2023
Q2Q % growth		 52.47M
155.70%		43.268M9.202M21.27%
Q1 2023
Q2Q % growth		 41.55M
161.65%		38.684M2.866M7.41%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS36.97% 77.39% 72.61% 82.06%
Revenue0.03% 12.22% -0.01% 10.8%